Literature DB >> 7989307

The subunit structure of elongation factor 1 from Artemia. Why two alpha-chains in this complex?

G M Janssen1, H T van Damme, J Kriek, R Amons, W Möller.   

Abstract

Elongation factor 1 (EF-1) regulates the specific interaction of aminoacyl-tRNA with the ribosome during the elongation phase of protein biosynthesis. Although individual functions of its separate chains have been well defined, to date there is hardly information about the structure and function of the whole complex. We describe here the complete subunit structure of elongation factor 1, and discuss its change during development of Artemia. Elongation factor 1 consists of a pentameric complex, composed of four different subunits alpha, beta, gamma, and delta in a molar ratio of 2:1:1:1. Although one molecule of EF-1 alpha dissociates easily from the complex EF-1 alpha 2 beta gamma delta under the influence of aminoacyl-tRNA and GTP, the second molecule of EF-1 alpha was found to remain firmly attached. Thus, in eukaryotic protein synthesis, movement of transfer RNAs to the ribosome seems under the influence of two distinct molecules of EF-1 alpha, a result possibly related to the presumed consumption of two molecules of GTP by EF-Tu during the elongation step of prokaryotic protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989307

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  A structural model for elongation factor 1 (EF-1) and phosphorylation by protein kinase CKII.

Authors:  G T Sheu; J A Traugh
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  The intracellular location of two aminoacyl-tRNA synthetases depends on complex formation with Arc1p.

Authors:  K Galani; H Grosshans; K Deinert; E C Hurt; G Simos
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser⁵³ is a novel substrate for protein kinase C βI.

Authors:  Manuela Piazzi; Alberto Bavelloni; Irene Faenza; William Blalock; Andrea Urbani; Simona D'Aguanno; Roberta Fiume; Giulia Ramazzotti; Nadir Mario Maraldi; Lucio Cocco
Journal:  Mol Cell Proteomics       Date:  2010-10-05       Impact factor: 5.911

4.  The C-terminal region of human eukaryotic elongation factor 1Bδ.

Authors:  Huiwen Wu; Chen Wang; Weibin Gong; Jinfeng Wang; Jinsong Xuan; Sarah Perrett; Yingang Feng
Journal:  J Biomol NMR       Date:  2016-01-13       Impact factor: 2.835

Review 5.  The plant translational apparatus.

Authors:  K S Browning
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

6.  eIF2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2. Sequence conservation between the alpha, beta and delta subunits of eIF2B from mammals and yeast.

Authors:  N T Price; H Mellor; B L Craddock; K M Flowers; S R Kimball; T Wilmer; L S Jefferson; C G Proud
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

7.  Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.

Authors:  Francisco Mansilla; Irene Friis; Mandana Jadidi; Karen M Nielsen; Brian F C Clark; Charlotte R Knudsen
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 8.  The many roles of the eukaryotic elongation factor 1 complex.

Authors:  Arjun N Sasikumar; Winder B Perez; Terri Goss Kinzy
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-05-03       Impact factor: 9.957

9.  FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.

Authors:  H Ishii; A Vecchione; Y Murakumo; G Baldassarre; S Numata; F Trapasso; H Alder; R Baffa; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

10.  Mutation of a conserved CDK site converts a metazoan Elongation Factor 1Bbeta subunit into a replacement for yeast eEF1Balpha.

Authors:  J R Pomerening; L Valente; T G Kinzy; T W Jacobs
Journal:  Mol Genet Genomics       Date:  2003-07-30       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.